Thurston, Springer, Miller, Herd & Titak, Inc. Cor Medix Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 1,500 shares of CRMD stock, worth $14,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$14,760% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRMD
# of Institutions
114Shares Held
17.7MCall Options Held
134KPut Options Held
441K-
Black Rock Inc. New York, NY3.55MShares$35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$30.2 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$15.3 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.28MShares$12.6 Million0.0% of portfolio
-
State Street Corp Boston, MA1.23MShares$12.1 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $405M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...